Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid

Leuk Res. 1991;15(8):765. doi: 10.1016/0145-2126(91)90081-4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Lomustine / administration & dosage
  • Male
  • Middle Aged
  • Stereoisomerism
  • Tretinoin / therapeutic use*

Substances

  • Cytarabine
  • Tretinoin
  • Etoposide
  • Lomustine
  • Daunorubicin